focus -WSS

focus

author：entertainment 2025-10-01 02:27:13 - browse：662

Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT — Bernard Moss Courtesy NIAID

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Fetal cell organoids grown from amniotic fluid, study finds

WSS

Physician subsidies by hospitals soar in wake of No Surprises Act

A new approach to psychiatric drug development

Medicare drug price negotiation hearing pits pharma v Biden admin

Telehealth options flood the market as retailers push virtual care

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

CDC recommends rationing of RSV shot due to shortages

hotspot

focus

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Streamlined flu vaccines recommended by FDA advisory panel

Supreme Court strikes down use of affirmative action

FDA has safety concerns on CRISPR

In age of alternative facts, a scholarly course on calling out crap

Biden's 'march

After affirmative action ruling, medical educators look to 'holistic review'

Stem cell biologist probes earliest stages of human development

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Telehealth options flood the market as retailers push virtual care

explore

Biden's order seeks to regulate AI risk without stifling innovation

Microsoft's Peter Lee: Generative AI could help doctors be more human

Maker of FluMist seeks to allow at

$1 billion proposal to grow Boston, Massachusetts biotech

Families look for replacement for GSK asthma drug Flovent

Readout Newsletter: BridgeBio, Akero, and human embryo models

entertainment

hotspot

focus

explore